8PIE | pdb_00008pie

Crystal structure of the human nucleoside diphosphate kinase B domain in complex with the product AT-8500 formed by catalysis of compound AT-9010


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free: 
    0.213 (Depositor), 0.218 (DCC) 
  • R-Value Work: 
    0.172 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8PIE

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolution.

Chazot, A.Zimberger, C.Feracci, M.Moussa, A.Good, S.Sommadossi, J.P.Alvarez, K.Ferron, F.Canard, B.

(2024) PLoS Biol 22: e3002743-e3002743

  • DOI: https://doi.org/10.1371/journal.pbio.3002743
  • Primary Citation Related Structures: 
    8PIE, 8PTS, 8PWK, 8QCH

  • PubMed Abstract: 

    Bemnifosbuvir (AT-527) and AT-752 are guanosine analogues currently in clinical trials against several RNA viruses. Here, we show that these drugs require a minimal set of 5 cellular enzymes for activation to their common 5'-triphosphate AT-9010, with an obligate order of reactions. AT-9010 selectively inhibits essential viral enzymes, accounting for antiviral potency. Functional and structural data at atomic resolution decipher N6-purine deamination compatible with its metabolic activation. Crystal structures of human histidine triad nucleotide binding protein 1, adenosine deaminase-like protein 1, guanylate kinase 1, and nucleoside diphosphate kinase at 2.09, 2.44, 1.76, and 1.9 Å resolution, respectively, with cognate precursors of AT-9010 illuminate the activation pathway from the orally available bemnifosbuvir to AT-9010, pointing to key drug-protein contacts along the activation pathway. Our work provides a framework to integrate the design of antiviral nucleotide analogues, confronting requirements and constraints associated with activation enzymes along the 5'-triphosphate assembly line.


  • Organizational Affiliation
    • Aix Marseille Université, CNRS, AFMB, UMR 7257, Marseille, France.

Macromolecule Content 

  • Total Structure Weight: 120.13 kDa 
  • Atom Count: 7,869 
  • Modeled Residue Count: 906 
  • Deposited Residue Count: 1,026 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Nucleoside diphosphate kinase B
A, B, C, D, E
A, B, C, D, E, F
171Homo sapiensMutation(s): 0 
Gene Names: NME2NM23B
EC: 2.7.4.6 (PDB Primary Data), 2.7.13.3 (PDB Primary Data)
UniProt & NIH Common Fund Data Resources
Find proteins for P22392 (Homo sapiens)
Explore P22392 
Go to UniProtKB:  P22392
PHAROS:  P22392
GTEx:  ENSG00000243678 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP22392
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
7QT

Query on 7QT



Download:Ideal Coordinates CCD File
G [auth A]
I [auth B]
J [auth C]
K [auth D]
L [auth E]
G [auth A],
I [auth B],
J [auth C],
K [auth D],
L [auth E],
M [auth F]
[(2~{R},3~{R},4~{R},5~{R})-5-(2-azanyl-6-oxidanylidene-1~{H}-purin-9-yl)-4-fluoranyl-4-methyl-3-oxidanyl-oxolan-2-yl]methyl phosphono hydrogen phosphate
C11 H16 F N5 O10 P2
LEEQMJUVDQBILY-GITKWUPZSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
H [auth A]GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
Modified Residues  1 Unique
IDChains TypeFormula2D DiagramParent
HIP
Query on HIP
A, B, C, D, E
A, B, C, D, E, F
L-PEPTIDE LINKINGC6 H11 N3 O5 PHIS

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.90 Å
  • R-Value Free:  0.213 (Depositor), 0.218 (DCC) 
  • R-Value Work:  0.172 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 54.19α = 90
b = 120.313β = 110.154
c = 71.918γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Other governmentFranceGrand Prix Scientifique de l'Institut de France -Fondation Simone et Cino Del Duca - 2022

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-31
    Type: Initial release
  • Version 1.1: 2024-09-04
    Changes: Database references